EpoprostenolHypertension, PulmonaryAntihypertensive AgentsDrug StorageIloprostInfusions, IntravenousAdministration, IntravenousPulmonary Veno-Occlusive DiseaseHemodynamicsTolazolineExercise TolerancePreservatives, PharmaceuticalSulfonesHemangioma, CapillaryVasodilator AgentsHeart-Lung TransplantationPurinesVascular ResistancePulmonary CirculationSulfonamidesAcenocoumarolPulmonary ArteryPulmonary Wedge PressureDrug StabilityHeart Septal DefectsHypertension, PortalChemistry, PharmaceuticalInfusions, ParenteralTreatment OutcomeExcipientsLung TransplantationPiperazinesBlood PressureConnective Tissue DiseasesBleeding TimeProstaglandinsDrug Therapy, CombinationPlatelet AggregationCardiac OutputAdministration, InhalationFollow-Up StudiesInjections, IntravenousPlatelet Aggregation InhibitorsDose-Response Relationship, DrugIsoxazolesReceptors, EpoprostenolInfusions, Intra-ArterialDrug Administration ScheduleVentricular Function, RightDrug EvaluationAdenosine DiphosphateAnticoagulantsPulmonary EmbolismAdministration, OralAngiographyRetrospective StudiesJapanSurvival Rate